| Code | 8254C | ||||||||||
| MA number | 41/0199/18-S | ||||||||||
| Product Form: | tbl 50x5 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Medreg s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 41 - CARDIACA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 14.06.2018 |
| Dokument: |
VHS_Bisoprolol Xantis.pdf
|
| Dokument: |
VHS_súhrn_Bisoprolol Xantis.pdf
|
| SPC: |
SPC_Bisoprolol Medreg_tbl_06_2023.pdf
|
| PIL: |
PIL_Bisoprolol Medreg_tbl_06_2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.09.2022 |
